CN103667186B - A kind of recovery totipotent method of mescenchymal stem cell - Google Patents

A kind of recovery totipotent method of mescenchymal stem cell Download PDF

Info

Publication number
CN103667186B
CN103667186B CN201210326437.5A CN201210326437A CN103667186B CN 103667186 B CN103667186 B CN 103667186B CN 201210326437 A CN201210326437 A CN 201210326437A CN 103667186 B CN103667186 B CN 103667186B
Authority
CN
China
Prior art keywords
cell
culture
totipotency
mescenchymal stem
stem cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210326437.5A
Other languages
Chinese (zh)
Other versions
CN103667186A (en
Inventor
吴耀炯
郭玲
周莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Graduate School Tsinghua University
Original Assignee
Shenzhen Graduate School Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Graduate School Tsinghua University filed Critical Shenzhen Graduate School Tsinghua University
Priority to CN201210326437.5A priority Critical patent/CN103667186B/en
Publication of CN103667186A publication Critical patent/CN103667186A/en
Application granted granted Critical
Publication of CN103667186B publication Critical patent/CN103667186B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a kind of recovery mesenchyma totipotent cultural method of dry small cell.The invention provides a kind of recovery mesenchyma totipotent method of dry small cell, comprise the steps: 1) by the in vitro mescenchymal stem cell Hanging drop culture of totipotency reduction, obtain the cell after Hanging drop culture;2) cell after described Hanging drop culture is continued the cultivation that suspends, it is achieved recover mesenchyma dry small cell totipotency.The experiment proves that, the invention provides a kind of recovery totipotent method of mescenchymal stem cell, the concrete 3D of employing cultivates, by through the mescenchymal stem cell (totipotency reduce in vitro mescenchymal stem cell) of repeatedly Secondary Culture after 3D cultivation processes, its volume increased gradually recovers, cytoactive strengthens, cloning capacity and differentiation capability strengthen, its paracrine action also increases, make old and feeble mescenchymal stem cell return to youth, recover stem cell properties.

Description

A kind of recovery totipotent method of mescenchymal stem cell
Technical field
The present invention relates to biological technical field, particularly relate to a kind of recovery totipotent method of mescenchymal stem cell.
Background technology
Mescenchymal stem cell (mesenchymal stem cells, MSCs) is a kind of adult stem cell, because it has by force Big multiplication capacity and multi-lineage potential, immunogenicity is low, convenient sources, it is easy to separates, cultivate, expand and purifying etc. is excellent Point so that it is there is wide potential applicability in clinical practice at the aspect such as autoimmune disease and various replacement therapies.Although marrow Middle mescenchymal stem cell content is the most, but only accounts for 0.001%~0.01%, it is difficult to meets the needs of cell therapy, therefore needs The most isolated and purified, cultivate amplification and could meet requirement.But, old and feeble and to Gegenbaur's cell in MSCs amplification procedure in vitro Self-differentiation problem has a strong impact on its result for the treatment of and safety in utilization.
Keep MSCs primary characteristic it is critical only that the condition of culture improving MSCs.MSCs is at a kind of three-dimensional in vivo Environment, it is thus proposed that the imagination of dimensional culture.1998, Qiu carried out dimensional culture to murine stromal cells, scanning Electronic Speculum detection finds that a large amount of cell in microcarrier cytodex-3 surface covers, and mutually bridges together, constitutes three-dimensional many cells Polymer.Visible Mineral nodules in polymer, alkaline phosphatase seen from immunohistochemical staining and 1 Collagen Type VI (Qiu Q, Ducheyne P,Gao H,Ayyaswamy P.Formation and differentiation of three- dimensional rat marrow stromal cell culture on microcarriers in a rotating- wall vessel.Tissue Eng.1998;4:19-34.).Glowacki collagen sponge carries out dimensional perfusion as carrier Cultivating, decrease the gathering of metabolite, found that Extracellular Matrix Content improves, cytoactive and the function cultivated are equal Strengthen (Glowacki J, Mizuno S, Greenberger JS.Perfusion enhances functions of bone marrow stromal cells in three-dimensional culture.Cell Transplant.1998;7:319- 26.).But cytodex-3 and collagen sponge are solid-core support, specific surface area is less, and cell is difficult to expand on a large scale.And carry greatly Can body bioreactor be used for the amplification cultivation of MSCS, and the smooth solution of some problems that need, such as macroporous microcarrier Development, cell and the adhesion of carrier, the wash-out etc. of attached cell.
Current 3D cultivation all can not meet current cell engineering and genetic engineering and form the demand of seed cell amount Industrialization, and, 3D cultivation has the most fundamentally recovered MSCs versatility the most not yet research.
Summary of the invention
It is an object of the present invention to provide a kind of recovery mesenchyma totipotent method of dry small cell.
The method that the present invention provides, comprises the steps:
1) in vitro mescenchymal stem cell Hanging drop culture totipotency reduced, obtains the cell after Hanging drop culture;
2) by after described Hanging drop culture cell continue suspend cultivate, it is achieved recover described totipotency reduce in vitro between fill Matter stem cell totipotency.
In said method, in step 1), the in vitro mescenchymal stem cell that described totipotency reduces is for do in vitro mesenchyma The mescenchymal stem cell that cell obtains through amplification in vitro.
Wherein, above-mentioned in vitro mescenchymal stem cell can derive from any human body or animal tissue and body fluid, such as placenta, navel Band, marrow, fat and/or Cord blood etc., and the totipotency of this in vitro mescenchymal stem cell is intact.
The in vitro mescenchymal stem cell that above-mentioned totipotency reduces can be caused by any reason, as caused by amplification in vitro is cultivated, Including culture system in vitro reason or the factor such as pass on;In embodiments of the invention, it is by amplification in vitro that above-mentioned totipotency reduces Cultivation causes, specially Secondary Culture 4-10 generation;Described Secondary Culture specifically uses the mode of adhere-wall culture.
The in vitro mescenchymal stem cell that above-mentioned totipotency reduces is characterized by: compared with in vitro mescenchymal stem cell, The volume of cell becomes big, shape is become irregular shape by fusiformis, the transparency of kytoplasm increases, independently to osteoblast differentiation, dry Cell relating gene-1 Oct4, Sox2, Nanog expression declines.
In said method, in step 1),
Described Hanging drop culture comprises the steps: that the in vitro mescenchymal stem cell described totipotency reduced suspends, and obtains Cell suspension;Again described cell suspension is dripped on culture dish lid, then the lid after dropping is upside down at the bottom of culture dish, training Support, obtain the cell after hanging drop is Hanging drop culture;The concentration of described cell suspension is specially 104-108Individual/mL.
The step of the in vitro mescenchymal stem cell digestion described totipotency reduced also is included before above-mentioned suspension.
In said method, described Hanging drop culture also comprises the steps:, before described cultivation, to add at the bottom of described culture dish Enter the water or solution preventing hanging drop to be dried;Described solution be concentration be 0.01M, pH value be 7.4 PBS, physiological saline, Cell culture fluid or other buffer solution.
In said method, described culture dish is cell or Micro-Organism Culture Dish;The material tool of described cell or Micro-Organism Culture Dish Body is plastics or glass.
In embodiments of the invention, Hanging drop culture is specific as follows:
1) in vitro mescenchymal stem cell totipotency reduced with digestive juice is digested to single cell suspension, with the DMEM of high sugar + 10%(weight/mass percentage composition) hyclone suspension, adjusting cell concentration in single cell suspension is 1 × 106Individual/mL, obtains slender Born of the same parents' suspension;
2) be about 35000 cells with the cell number of every 35 μ l(every) volume above-mentioned cell suspension is dripped uniformly Being added in the lid of diameter 9cm Micro-Organism Culture Dish (the most adherent culture dish), each Micro-Organism Culture Dish lid hanging drop drips numerical control system 40 Drip, more careful the reversing of Micro-Organism Culture Dish lid cover the PBS(concentration equipped with 10ml be 0.01M, pH value be 7.4) at the bottom of culture dish On;It is placed in incubator, stands Hanging drop culture 36h, obtain hanging drop.
Above-mentioned digestion use digestive juice be pancreatin and EDTA are dissolved in concentration be 0.01M, pH value be 7.4 PBS buffering The solution that liquid obtains, the wherein pancreatin final concentration of 0.25%(weight/mass percentage composition in digestive juice), EDTA is in digestive juice Final concentration of 0.02%(weight/mass percentage composition).
In said method, the culture medium of suspend in described the Hanging drop culture suspension used and described suspension cultivation employing is equal For cell culture medium or containing following 1)-3) in the cell culture medium of at least one component:
1) cell growth components is promoted: serum, growth factor, cell factor, trace element, hormone, vitamin, cell are believed Number pathway inhibitor and/or activator;
2) help cell attachment component: collagen, gelatin, hyaluronic acid, cellulose, chondroitin sulfate, peptide, chitin, PLA and/or hydrogel;
3) component that antipathogen infects: antibiotic.
Above-mentioned cell culture medium is the culture medium cultivating mescenchymal stem cell;The culture medium of described cultivation mescenchymal stem cell For the DMEM in high glucose culture medium containing hyclone, specifically it is prepared as follows: hyclone is cultivated with DMEM in high glucose The cell culture medium that base is mixed to get, described hyclone concentration in described cell culture medium is that 10%(percent mass contains Amount).
In said method, the time of described Hanging drop culture is 2-110 hour;It is specially 36h;
The described time cultivated that suspends is 2-110 hour;It is specially 24h;
The condition that described Hanging drop culture and described suspension are cultivated is as follows: oxygen concentration is 0.1-50%, CO2Concentration is 1-15%, Temperature is 30-40 ° of C;
Described Hanging drop culture and described suspension are cultivated and are static culture or dynamic cultivation;The mode of described dynamic cultivation is Stir, rotate or shake.
In said method, recover described totipotency reduce in vitro mescenchymal stem cell totipotency be embodied in reduction described entirely Can the in vitro mescenchymal stem cell that reduces of property volume, reduce in vitro mescenchymal stem cell S phase thin that described totipotency reduces Born of the same parents' quantity, strengthen described totipotency reduce in vitro mescenchymal stem cell differentiation capability, strengthen described totipotency reduce from The cloning capacity of body mescenchymal stem cell and/or improve in the in vitro mescenchymal stem cell that described totipotency reduces with totipotency phase Correlation gene is expressed;
Described with totipotency related gene be CCR1, CCR2, CX3CR, CD49b, CXCR4, OCT4, SOX2 and/or NANONG。
The mescenchymal stem cell obtained by above-mentioned method is also the scope of protection of the invention.
It is a further object to provide a kind of mesenchyma dry small cell cultural method.
The method that the present invention provides, including the step of above-mentioned method.
The experiment proves that, the invention provides a kind of recovery totipotent method of mescenchymal stem cell, specifically adopt Cultivate with 3D, by the mescenchymal stem cell (mescenchymal stem cell that totipotency reduces) through repeatedly Secondary Culture at 3D cultivation After reason, its volume increased gradually recovers, cytoactive strengthens, cloning capacity and differentiation capability strengthen, its paracrine action also Increasing, these results illustrate, the method that this kind of 3D cultivates, and make old and feeble mescenchymal stem cell return to youth, recover Stem cell properties;And this method uses a kind of regulatable undamaged physical means, external regulation human mesenchyme is dry thin The versatility of born of the same parents and differentiation capability, it is achieved that the maintenance of amplification in vitro mescenchymal stem cell and recovery, and then solve the human world and fill A difficult problem in the clinical practice of matter stem cell, has preferable economic benefit and social benefit.It addition, the MSCs that totipotency is recovered Have the advantage that there is extremely low immunogenicity, because of without causing rejection as the seed cell transplanted;It is not related to Ethics problem of embryonic stem cell etc..
Accompanying drawing explanation
Fig. 1 is that the MSCs versatility of adhere-wall culture reduces
Fig. 2 is the formation of the MSCs cell ball that 3D cultivates
Fig. 3 is the change of the MSCs cell size form that 3D cultivates
Fig. 4 is that 3D cultivates cell cycle and the impact of apoptosis
Fig. 5 is the impact that 3D cultivates on MSCs differentiation capability
Fig. 6 is the impact that 3D cultivates on MSCs cloning capacity
Fig. 7 is the expression of the MSCs totipotency related gene that 3D cultivates
Detailed description of the invention
Experimental technique used in following embodiment if no special instructions, is conventional method.
Material used in following embodiment, reagent etc., if no special instructions, the most commercially obtain.
In following embodiment, in vitro mescenchymal stem cell (mesenchymal stem cells, MSCs) is purchased from Cyagen Biosciences Inc, catalog number are HUXMA-01001, it is also possible to be prepared as follows: pancreatin separates in vitro people Marrow, umbilical cord or placenta mesenchyma stem cell, then collect cell and cultivate, when cell reaches the fusion of 70%-80%, use D- After PBS, pancreatin processes, and is subsequently adding complete medium and terminates digestion, blow and beat into single cell suspension, is centrifuged and removes supernatant, complete After full culture medium is resuspended, Secondary Culture.
In following embodiment, Micro-Organism Culture Dish (the most adherent culture dish) reaches the limited public affairs of scientific and technological development purchased from Wuhan cause sincerity Department, catalog number is TCD000090.
Digestive juice in following embodiment is pancreatin and EDTA be dissolved in concentration be 0.01M, pH value be the PBS of 7.4 The solution obtained, the wherein pancreatin final concentration of 0.25%(weight/mass percentage composition in digestive juice), EDTA end in digestive juice Concentration is 0.02%(weight/mass percentage composition).
In following embodiment concentration be 0.01M, pH value be 7.4 PBS formula as follows: NaCl 8.00g, Na2HPO4.12H2O 2.90g, KCl 0.2g, KH2PO4 0.24g。
In following embodiment, cell culture condition can use: oxygen concentration is 0.1-50%, CO2Concentration is 1-15%, and temperature is 30-40 ° of C, being specifically oxygen concentration is 10%, CO2Concentration is 2%, and temperature is 37 ° of C;
Embodiment 1, totipotency reduce the acquisition of mescenchymal stem cell
One, the subculture in vitro separately adhere-wall culture of mescenchymal stem cell
In vitro mescenchymal stem cell (MSCs) is cultivated in low sugar DMEM of the hyclone (FBS, Gibco) containing 10% Adherent Secondary Culture in base (Hyclone, SH30021.01B), the time of each Secondary Culture is 3 days, respectively obtains 1-10 For adherent MSCs.
Two, cellular omnipotency detection after adhere-wall culture
1), the morphologic change of MSCs after adhere-wall culture
Being seeded in overnight incubation (12h) in six orifice plates by after 1st generation and the 10th culture MSCs cell dissociation, second day general Logical light microscope 10 × object lens are observed;Result as shown in figs. ia-b, as can be seen from the results, 1st generation and the 10th culture It is further cultured for after MSCs cell dissociation respectively obtaining 2nd generation (p2) and the 12nd generation (p11) MSCs cell, along with the increasing of passage number Many, the volume of cell starts to become big, and shape also becomes irregular by fusiformis;From basis of microscopic observation, cell increases at volume During great, it is inconspicuous that border becomes, and the transparency of kytoplasm increases.It can be seen that the totipotency of adherent MSCs reduces.
Using same method detection adhere-wall culture the 4th, the adherent MSC in 6 generations, also occur that volume increases, totipotency reduces Result.
2), the MSCs of adhere-wall culture is independently to osteoblast differentiation
The adherent MSC in adhere-wall culture the 4th generation carries out alkaline phosphatase staining;Result such as Fig. 1 C shows there is a few cell body Amass and substantially flatten greatly, and in alkaline phosphatase staining positive (red), present autonomous to osteoblastic feature.Can see Going out, the totipotency of adherent MSCs reduces, autonomous to a direction osteoblast differentiation without induction.
Use same method detection adhere-wall culture the 6th, the adherent MSC in 10 generations, also occur autonomous to a direction skeletonization The result of cell differentiation.
3), the expression of the MSCs totipotency related gene of adhere-wall culture
In the MSCs of the different generation adhere-wall culture of real-time fluorescence quantitative PCR inspection totipotency gene OCT4, SOX2 and The expression of NANONG: its primer sees below table 1.ApplicationRT reagent Kit (TaKaRa) kit enters Row reverse transcription reaction and usePremix Ex TaqTMII (TaKaRa) kit is carried out at ABI 7300QPCR instrument Real-time fluorescence quantitative PCR reacts.Reverse transcription reaction: 16 ° of C, 30min;42 ° of C, 30s;85 ° of C, enzyme-deactivating 5s;Regularly fluorescent quantitation Reaction: 95 ° of C denaturations 10min;95 ° of C sex change 15s;60 ° of C annealing 60s, 40 circulations carry out PCR amplification.GAPDH is as interior Ginseng, Δ Δ Ct method relative quantification.
Part of test results such as Fig. 1 D shows, along with the increase of MSCs passage number, stem cell related gene Oct4, Sox2, Nanog expression all occurs in that decline (the 6th generation was less than 2nd generation) in various degree.
Using same method detection the 4th, the adherent MSC in 10 generations, expression is below the adherent MSCs of 2nd generation.
It can be seen from the results above that after adhere-wall culture, along with passage number increases, the totipotency of MSCs is gradually lowered. Therefore, compared with initial in vitro mescenchymal stem cell, the 4th generation adherent MSCs, the 6th generation adherent MSCs, the 10th generation adherent MSCs It is the mescenchymal stem cell that totipotency reduces.
Embodiment 2, the recovery totipotent cultivation of mescenchymal stem cell
(in the 4th generation adherent MSCs, the 6th generation, are adherent for mescenchymal stem cell that the totipotency that obtained by above-described embodiment 1 reduces MSCs, the 10th generation adherent MSCs) carry out following two groups of process respectively:
A group: adhere-wall culture: cultural method ibid, obtains the 5th generation adherent MSCs, the 7th generation adherent MSCs, the 11st generation adherent MSCs。
B group: 3D cultivates, and cultural method is as follows:
1, Hanging drop culture
With digestive juice, the 4th generation adherent MSCs, the 6th generation adherent MSCs, the 10th generation adherent MSCs are digested to unicellular respectively Suspension, with the DMEM(GIBCO, C11995 of high sugar)+10%(weight/mass percentage composition) hyclone, adjust in single cell suspension thin Born of the same parents' concentration is 1 × 106Individual/mL, obtains single cell suspension;
Be about 35000 cells with the cell number of every 35 μ l(every) volume above-mentioned cell suspension is dripped uniformly In the lid of diameter 9cm Micro-Organism Culture Dish (the most adherent culture dish), each Micro-Organism Culture Dish lid hanging drop drips numerical control system at 40, The most careful the reversing of Micro-Organism Culture Dish lid cover the PBS(concentration equipped with 10ml be 0.01M, pH value be 7.4, sigma, article No.: On 051M8311) at the bottom of culture dish;It is placed in incubator, stands Hanging drop culture 36h, obtain hanging drop.
2, suspend cultivation
Collect hanging drop and be placed in the Micro-Organism Culture Dish continuation standing equipped with 10ml culture medium (DMEM in high glucose+10% hyclone) Suspend cultivate 24h, one co-cultures 60h, obtain the 5th generation 3D cultivate MSCs cell ball, the 7th generation 3D cultivate MSCs cell ball, the 11st MSCs cell ball is cultivated for 3D.
The forming process of above-mentioned cell ball is as shown in Figure 2 (as a example by the 5th generation MSCs cell ball), and A is Hanging drop culture 4h;B For Hanging drop culture 12h;C is Hanging drop culture 24h;D is Hanging drop culture 36h;E is Hanging drop culture 48h;Cell ball under F:10 × object lens Form, it can be seen that Hanging drop culture 36h i.e. can get cell ball.
3, digestion
The 5th generation 3D obtained above-mentioned 2 cultivates MSCs cell ball, the 7th generation 3D cultivates MSCs cell ball, the 11st generation 3D cultivates MSCs cell ball is washed twice through PBS respectively, digests 10min with digestive juice, obtains the 5th generation, the 7th generation and the 11st generation 3D and cultivates MSCs Cell.
Use same method the 5th generation of digestion, the 7th generation and the MSCs of the 11st generation adhere-wall culture, the 5th generation after being digested, 7th generation and the 11st generation adhere-wall culture MSCs cell.
Three, the totipotency of mescenchymal stem cell after detection 3D cultivates
3D in following test experience cultivates MSCs cell and adherent MSCs cell is postdigestive cell.
1, the change of MSCs biological morphology after 3D cultivates
5th generation, the 7th generation and the 11st generation 3D cultivation MSCs cell is seeded in overnight incubation (12h) in six orifice plates respectively, the Within two days, ordinary optical microscope is observed;With the 5th generation, the 7th generation and the 11st generation adherent MSCs cell for comparison.
Result is as it is shown on figure 3, result that Fig. 3 A is the 11st generation adherent MSCs cell;Fig. 3 B is that the 11st generation 3D cultivation MSCs is thin Born of the same parents' result;It can be seen that 3D cultivates cellular morphology starts again to revert to fusiformis, volume diminishes, more third dimension.
Fig. 3 C is the 5th generation and the 7th generation 3D cultivation MSCs cell, the 5th generation and the size at the 7th generation adherent MSCs forward reflection angle Relatively;It can be seen that compared with attached cell, the forward reflection angle in the 5th generation and the 7th generation cell that 3D cultivates MSCs diminishes, and says After bright 3D cultivation, the volume of cell reduces (reducing about 42%).
Fig. 3 D is that the 10 × object lens of the 5th generation adherent MSCs are observed;Fig. 3 E is 10 × object lens that the 5th generation 3D cultivates MSCs cell Observe;It can be seen that the volume of cell is obviously reduced after 3D cultivation.
2,3D cultivates apoptosis and the cell cycle of MSCs
5th generation adherent MSCs and the 5th generation 3D is cultivated MSCs cell PI(P-4170, sigma) dyeing 30min, streaming Cell instrument detection cell cycle distribution situation.Shown in result as Fig. 4 A-B, A is the cell cycle distribution of the 5th generation adherent MSCs;B It it is the cell cycle distribution of the 5th generation 3D cultivation MSCs cell;It can be seen that after 3D cultivates, the cell of S phase significantly reduces (patch Wall is cultivated: 24.92%;3D cultivates: 3.73%), cell is mostly in resting stage, thus maintains the characteristic of MSCs.
5th generation adherent MSCs and the 5th generation 3D are cultivated MSCs cell Annexin V/PI(invitrogen, 944090) double After dyeing 1h, flow cytometer detection Apoptosis.Result is shown in the Apoptosis that Fig. 4 C-D, C are the 5th generation adherent MSCs;D is the 5th generation 3D Cultivate the Apoptosis of MSCs cell;It can be seen that the apoptosis rate of cell is 4.2%+0.7% after 3D cultivation, dead cell is 3.3%, and the cell of major part (91%) is living cells;The survival rate of the cell of 3D cultivation and adhere-wall culture, without significant difference, is said Bright 3D cultivates will not reduce cell survival rate.
3, the MSCs differentiation capability that 3D cultivates
1) the MSCs skeletonization direction differentiation that, induction 3D cultivates
Osteogenic induction is cultivated: be counted as 5 × 104Individual/ml the 5th generation adherent MSCs(is adherent) and it is counted as 5 × 104Individual/ml 5 generation 3D cultivate MSCs cell (3D cultivation) inoculate in six orifice plates respectively, cell reach 80% converge after change fat induction broth into (10% hyclone, 0.1 μm ol/L dexamethasone, 50 μm ol/L ascorbic acid, the high sugar of 10mmol/L sodium β-glycerophosphate DMEM culture medium) carry out osteogenic induction cultivation, within every 3 days, change a not good liquor.With do not carry out Fiber differentiation for comparison, addition is normal Rule nutrient solution (the L-DMEM nutrient solution containing 10%FBS).
Respectively taking each group of cell when inducing 14d and carry out Alizarin red staining, light Microscopic observation is also photographed, and result is shown in Fig. 5 A-D institute Showing, wherein, A is adherent induction;B is that 3D cultivation is not induced;C is adherent induction;D is that 3D cultivates induction;It can be seen that do not lure Leading, both cells are without significant difference;After induction, the ability of the MSCs Osteoblast Differentiation that 3D cultivates is higher than adhere-wall culture MSCs。
2), the MSCs that induction 3D cultivates becomes Adipose Differentiation
It is counted as 5 × 104The 5th generation adherent MSCs(of individual/ml is adherent) and it is counted as 5 × 104The 5th generation 3D of individual/ml cultivates MSCs cell (3D cultivation) is inoculated in culture dish respectively, cell reach 80% converge after change into fat induction broth (L-DMEM train Nutrient solution, 10%FBS, dexamethasone 10-6Mol/L, insulin 10mg/L, 3-isobutyl-1-methylxanthine (3-isobutyl-1- Methylxanthine, IBMX) 0.5mmol/L, Indomethacin 0.2mmol/L) carry out fat induction differentiation cultivation, within every 3 days, change One not good liquor.With do not carry out Fiber differentiation for comparison, addition for cellar culture liquid (the L-DMEM nutrient solution containing 10%FBS).
Respectively taking each group of cell when inducing 14d and carry out oil red O stain, light Microscopic observation is also photographed, and result is shown in Fig. 5 E-H institute Showing, E is adherent induction;F is that 3D cultivation is not induced;G is adherent induction;H is that 3D cultivates induction;It can be seen that do not induce, this Two kinds of cells are without significant difference;After induction, the MSCs that 3D cultivates becomes the ability MSCs higher than adhere-wall culture of Adipose Differentiation.
4, the MSCs cloning capacity detection that 3D cultivates
5th generation adherent MSCs(is adherent) and the 5th generation 3D cultivate MSCs cell (3D cultivation) be suspended in 10% hyclone respectively DMEM nutrient solution in standby.
Above-mentioned each group of 200 cells are inoculated respectively containing (the L-DMEM cultivation containing 10%FBS of 37 ° of C pre-temperature nutrient solutions of 10mL Liquid) ware in, and rotate gently, make cell be uniformly dispersed.Put 37 ° of C 5%CO2And the cell culture incubator of saturated humidity is cultivated 2 Week.When culture dish occurs macroscopic clone, carefully embathe with PBS 2 times.Adding 2ml4% paraformaldehyde, fixing cell is solid Fixed 15 minutes.Removing fixer, add appropriate crystal violet dye liquor and contaminate 30 minutes, then slowly wash away dyeing liquor with flowing water, air is dried. Clone's number of 10 cells it is more than at microscope (low power lens) counting.Finally calculate cloning efficiency ((Clone formation number/inoculation Cell number) * 100%).
As shown in Figure 6, A is the clone that blue line is arranged above three multiple holes of adhere-wall culture to result, and lower section is that 3D cultivates Clone's number;B be adhere-wall culture and 3D cultivate cloning efficiency (adherent con for 19%, 3D for 41%);C is 10 × object lens The colony morphology of lower adhere-wall culture;D is the colony morphology that under 10 × object lens, 3D cultivates, it can be seen from the results above that train through 3D After Yanging, clone's number of MSCs has all had significant raising from quantity or quality.
5, the expression of the MSCs totipotency related gene that 3D cultivates
Inspection the 5th generation adherent MSCs(is adherent for real-time fluorescence quantitative PCR, con) and the 5th generation 3D cultivates MSCs cell, and (3D trains Support) in migrate related gene CCR1, CCR2, CX3CR, CD49b, CXCR4, the table of totipotency gene OCT4, SOX2 and NANONG Reach: its primer is shown in Table 1.ApplicationRT reagent Kit (TaKaRa) kit carry out reverse transcription reaction and WithPremix Ex TaqTMII (TaKaRa) kit carries out real-time fluorescence quantitative PCR at ABI 7300QPCR instrument Reaction.Reverse transcription reaction: 16 ° of C, 30min;42 ° of C, 30s;85 ° of C, enzyme-deactivating 5s;Regularly fluorescent quantitation reaction: 95 ° of C denaturations 10min;95 ° of C sex change 15s;60 ° of C annealing 60s, 40 circulations carry out PCR amplification.GAPDH is as internal reference, and Δ Δ Ct method is relative Quantitatively.
Table 1 is the primer of totipotency related gene
Gene EMBL-database Oligonucleotide(5’-3’)
CCR1 NM001295 For ACCATAGGAGGCCAACCCAAAATA (sequence 1)
Rev TCCATGCTGTGCCAAGAGTCA (sequence 2)
CCR2 NM000647 For CTACCTTCCAGTTCCTCATTTTT (sequence 3)
RevACATTTACAAGTTGCAGTTTTCAGC (sequence 4)
CX3CR NM001337 For ATAGATTCCCCATTGCCTCCTC (sequence 5)
Rev GGTTTTTCTATTTCCCTTACTGG (sequence 6)
CX3CR NM001337 For TGACTGGCAGATCCAGAGGTT (sequence 7)
Rev GTAGAATATGGACAGGAACAC(sequence 8)
CXCR4 NM003467 For ATCCCTGCCCTCCTGCTGACTATTC(sequence 9)
Rev GAGGGCCTTGCGCTTCTGGTG(sequence 10)
OCT4 NM002701 For GTATTCAGCCAAACGACCATC(sequence 11)
Rev CTGGTTCGCTTTCTCTTTCG (sequence 12)
Nanog NM_024865.2 For AATACCTCAGCCTCCAGCAGATG(sequence 13)
Rev TGCGTCACACCATTGCTATTCTTC(sequence 14)
Sox2 NM_003106 For GGGAAATGGGAGGGGTGCAAAAGAGG (sequence 15)
Rev TTGCGTGAGTGTGGATGGGATTGGTG (sequence 16)
Result is as it is shown in fig. 7, A is the mrna expression migrating related gene CCR1/CCR2/CX3CR/CD49b;Can see Going out, the mrna expression migrating related gene CCR1/CCR2/CX3CR/CD49b after 3D cultivates in MSC significantly improves;
B is the mrna expression of CXCR4;It can be seen that in MSC, the mrna expression of CXCR4 is traditional patch after 3D cultivates More than 2000 times of wall cultivation;
C is the mrna expression of versatility related gene OCT4, SOX2, NANOG;It can be seen that through 3D cultivate after MSC in The expression of OCT4, SOX2, NANOG substantially increases.
Above-mentioned experimental result illustrates, 3D cultivates the cellular-restoring totipotency that can totipotency be reduced.

Claims (2)

1. recover the mesenchyma totipotent method of dry small cell, comprise the steps:
1) in vitro mescenchymal stem cell Hanging drop culture totipotency reduced, obtains the cell after Hanging drop culture;
2) cell after described Hanging drop culture is continued the cultivation that suspends, it is achieved the in vitro mesenchyma recovering the reduction of described totipotency is done Cellular omnipotency;
Step 1) in, the in vitro mescenchymal stem cell that described totipotency reduces is for obtain in vitro mescenchymal stem cell through amplification in vitro The mescenchymal stem cell arrived;
Described amplification in vitro was cultivated as Secondary Culture 4-10 generation;Described Secondary Culture uses the mode of adhere-wall culture;
The in vitro mescenchymal stem cell totipotency that the described totipotency of described recovery reduces is embodied in and reduces what described totipotency reduced The volume of in vitro mescenchymal stem cell, reduce the cell quantity of in vitro mescenchymal stem cell S phase, enhancing that described totipotency reduces The differentiation capability of the in vitro mescenchymal stem cell that described totipotency reduces, to strengthen the in vitro mesenchyma that described totipotency reduces dry thin The cloning capacity of born of the same parents and/or improve in the in vitro mescenchymal stem cell that described totipotency reduces with totipotency related gene expression;
Described is CCR1, CCR2, CX3CR, CD49b, CXCR4, OCT4, SOX2 and/or NANONG with totipotency related gene;
Step 1) in, described Hanging drop culture comprises the steps: that the in vitro mescenchymal stem cell described totipotency reduced suspends, Obtain cell suspension;Again described cell suspension is dripped on culture dish lid, then the lid after dropping is upside down at the bottom of culture dish, Cultivate, obtain the cell after hanging drop is Hanging drop culture;
The concentration of described cell suspension is 104-108Individual/mL;
Described Hanging drop culture also comprises the steps: before described cultivation, adds and prevent hanging drop to be dried at the bottom of described culture dish Water or solution;Described solution be concentration be 0.01M, pH value be 7.4 PBS, physiological saline, cell culture fluid or its Its buffer solution;
Described culture dish is cell or Micro-Organism Culture Dish;The material of described cell or Micro-Organism Culture Dish is plastics or glass;
Described Hanging drop culture suspends use suspension and described suspension cultivate use culture medium be cell culture medium or Containing following 1)-3) in the cell culture medium of at least one component:
1) cell growth components is promoted: serum, growth factor, cell factor, trace element, hormone, vitamin, cell signal are logical Road inhibitor and/or activator;
2) component of cell attachment is helped: collagen, gelatin, hyaluronic acid, cellulose, chondroitin sulfate, peptide, chitin, poly-breast Acid and/or hydrogel;
3) component that antipathogen infects: antibiotic;
The time of described Hanging drop culture is 2-110 hour;
The described time cultivated that suspends is 2-110 hour;
The condition that described Hanging drop culture and described suspension are cultivated is as follows: oxygen concentration is 0.1-50%, CO2Concentration is 1-15%, temperature For 30-40 DEG C;
Described Hanging drop culture and described suspension are cultivated and are static culture or dynamic cultivation;The mode of described dynamic cultivation is for stirring Mix, rotate or shake.
2. a mesenchyma dry small cell cultural method, including the step of the method described in claim 1.
CN201210326437.5A 2012-09-06 2012-09-06 A kind of recovery totipotent method of mescenchymal stem cell Active CN103667186B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210326437.5A CN103667186B (en) 2012-09-06 2012-09-06 A kind of recovery totipotent method of mescenchymal stem cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210326437.5A CN103667186B (en) 2012-09-06 2012-09-06 A kind of recovery totipotent method of mescenchymal stem cell

Publications (2)

Publication Number Publication Date
CN103667186A CN103667186A (en) 2014-03-26
CN103667186B true CN103667186B (en) 2016-08-17

Family

ID=50305963

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210326437.5A Active CN103667186B (en) 2012-09-06 2012-09-06 A kind of recovery totipotent method of mescenchymal stem cell

Country Status (1)

Country Link
CN (1) CN103667186B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI525193B (en) * 2014-10-20 2016-03-11 國璽幹細胞應用技術股份有限公司 Uses of trans-cinnamaldehyde
CN106854639A (en) * 2015-12-08 2017-06-16 中国药科大学 One kind is based on three-dimensional semisolid adult stem cell cultural method
CN106834223B (en) * 2017-04-05 2020-03-27 上海逍鹏生物科技有限公司 Method for inducing differentiation of umbilical cord mesenchymal stem cells into chondrocytes
CN110894493A (en) * 2019-10-28 2020-03-20 吉林大学 Reprogramming mesenchymal stem cells and preparation method thereof
CN112725276A (en) * 2021-01-14 2021-04-30 香港再生医学有限公司 Suspension shaking culture method for improving yield of MSC (mesenchymal stem cell) differentiated into neural precursor cells
CN112870445A (en) * 2021-01-29 2021-06-01 周建大 Preparation method and application of soft tissue repair material
CN113106059B (en) * 2021-04-07 2023-08-15 清华大学深圳国际研究生院 High-migration mesenchymal stem cells, and preparation method and application thereof
CN113662966B (en) * 2021-07-09 2023-01-24 广东医科大学 Activating vesicle-containing hydrogel for promoting hair regeneration and medicinal application thereof
CN115644164A (en) * 2022-05-09 2023-01-31 深圳市三启生物技术有限公司 Preparation method of cell preservation solution and cell preservation solution prepared by preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011094572A3 (en) * 2010-01-28 2011-12-29 Shuichi Takayama Hanging drop devices, systems and/or methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011094572A3 (en) * 2010-01-28 2011-12-29 Shuichi Takayama Hanging drop devices, systems and/or methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
application of hanging drop technique for stem cell differentiation and cytotoxicity studies;meenal banerjee et al.;《cytotechnology》;20060531;第51卷(第1期);1-5 *
悬滴培养诱导大鼠骨髓间充质干细胞分化为肝样细胞;张奇好等;《中国病理生理杂志》;20101231;第26卷(第11期);第2208页第1节-右栏第一页,第2211页左栏第一段 *

Also Published As

Publication number Publication date
CN103667186A (en) 2014-03-26

Similar Documents

Publication Publication Date Title
CN103667186B (en) A kind of recovery totipotent method of mescenchymal stem cell
CN103805562B (en) Cultivate the serum free medium of placenta mesenchyma stem cell
Santos et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions
Chong et al. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells
CN107236704B (en) From the method for placenta separating mesenchymal stem cell and the digestive enzyme compositions used
CN102676451B (en) Method for separating mesenchymal stem cells from placenta
Sun et al. Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential
CN102586184B (en) Method for establishing placental mesenchyme stem cell library
CN102191218B (en) Complete medium and human amnion-derived mesenchymal stem cell culture method
Saleh et al. Turning round: multipotent stromal cells, a three-dimensional revolution?
CN106520676B (en) The method and its application of human amnion membrane are prepared from Human plactnta amnion
CN103146647B (en) Method for culturing mesenchymal stem cell in vitro
CN109234229B (en) Method for separating mesenchymal stem cells from placental blood vessels and digestive enzyme composition used in same
CN107022521A (en) Decidua vera tissue freezing, the method recovered and be separately cultured mescenchymal stem cell
CN103060266A (en) Method for separating and cultivating II-type epithelial cells of people alveolus pulmonis
Schmidt et al. The interplay between cell adhesion cues and curvature of cell adherent alginate microgels in multipotent stem cell culture
Loubière et al. Impact of the type of microcarrier and agitation modes on the expansion performances of mesenchymal stem cells derived from umbilical cord
CN104651305A (en) Method for acquiring bioactive proteins by utilizing umbilical cord mesenchymal stem cells
CN101831403B (en) Method for amplifying mesenchymal stem cells of human umbilical cord and placenta in vitro
Zhou et al. Ex vivo expansion of bone marrow mesenchymal stem cells using microcarrier beads in a stirred bioreactor
Choi et al. In vitro expansion of human adipose-derived stem cells in a spinner culture system using human extracellular matrix powders
CN104046589B (en) A kind of method of co-culture of cells induction stem cell in vitro directed differentiation
CN113322231A (en) Method for separating and culturing mesenchymal stem cells and preparation
Dai et al. Development of a novel feeding regime for large scale production of human umbilical cord mesenchymal stem/stromal cells
CN107574143B (en) Method for separating endothelial progenitor cells from cryopreserved cord blood

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant